Pu L[au] - Search Results

Year	Number of Results
1977	1
1986	1
1987	2
1989	2
1990	3
1991	2
1992	3
1993	3
1994	4
1995	11
1996	7
1997	5
1998	6
1999	12
2000	6
2001	9
2002	10
2003	11
2004	12
2005	18
2006	21
2007	37
2008	20
2009	32
2010	38
2011	16
2012	39
2013	49
2014	36
2015	55
2016	63
2017	74
2018	69
2019	78
2020	105
2021	127
2022	171
2023	142
2024	57

1

Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners.

Li Q, Zhang L, Yang Q, Li M, Pan X, Xu J, Zhong C, Yao F, Zhang R, Zhou S, Dai X, Shi X, Dai Y, Xu J, Cheng X, Xiao W, She Z, Wang K, Qian X, Pu L, Zhang P, Wang X. Li Q, et al. Among authors: pu l. Cell Metab. 2023 Jun 6;35(6):912-927.e7. doi: 10.1016/j.cmet.2023.03.017. Epub 2023 Apr 17. Cell Metab. 2023. PMID: 37071992

2

Reduced Mitochondrial Protein Translation Promotes Cardiomyocyte Proliferation and Heart Regeneration.

Gao F, Liang T, Lu YW, Pu L, Fu X, Dong X, Hong T, Zhang F, Liu N, Zhou Y, Wang H, Liang P, Guo Y, Yu H, Zhu W, Hu X, Chen H, Zhou B, Pu WT, Mably JD, Wang J, Wang DZ, Chen J. Gao F, et al. Among authors: pu l. Circulation. 2023 Dec 5;148(23):1887-1906. doi: 10.1161/CIRCULATIONAHA.122.061192. Epub 2023 Oct 31. Circulation. 2023. PMID: 37905452

3

PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells.

Li Q, Zhang L, You W, Xu J, Dai J, Hua D, Zhang R, Yao F, Zhou S, Huang W, Dai Y, Zhang Y, Baheti T, Qian X, Pu L, Xu J, Xia Y, Zhang C, Tang J, Wang X. Li Q, et al. Among authors: pu l. Nat Commun. 2022 Dec 12;13(1):7677. doi: 10.1038/s41467-022-35469-x. Nat Commun. 2022. PMID: 36509766 Free PMC article.

4

Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma.

Zhang L, Xu J, Zhou S, Yao F, Zhang R, You W, Dai J, Yu K, Zhang Y, Baheti T, Pu L, Xu J, Qian X, Zhang C, Xia Y, Dai X, Li Q, Wang X. Zhang L, et al. Among authors: pu l. J Hepatol. 2024 Jan;80(1):82-98. doi: 10.1016/j.jhep.2023.10.006. Epub 2023 Oct 12. J Hepatol. 2024. PMID: 37838036

5

A defect in mitochondrial protein translation influences mitonuclear communication in the heart.

Gao F, Liang T, Lu YW, Fu X, Dong X, Pu L, Hong T, Zhou Y, Zhang Y, Liu N, Zhang F, Liu J, Malizia AP, Yu H, Zhu W, Cowan DB, Chen H, Hu X, Mably JD, Wang J, Wang DZ, Chen J. Gao F, et al. Among authors: pu l. Nat Commun. 2023 Mar 22;14(1):1595. doi: 10.1038/s41467-023-37291-5. Nat Commun. 2023. PMID: 36949106 Free PMC article.

6

Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data.

Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, Han L. Che B, et al. Among authors: pu l. Cardiovasc Diabetol. 2023 Feb 16;22(1):34. doi: 10.1186/s12933-023-01762-2. Cardiovasc Diabetol. 2023. PMID: 36797706 Free PMC article.

7

A predictive model for the risk of cognitive impairment in community middle-aged and older adults.

Pu L, Pan D, Wang H, He X, Zhang X, Yu Z, Hu N, Du Y, He S, Liu X, Li J. Pu L, et al. Asian J Psychiatr. 2023 Jan;79:103380. doi: 10.1016/j.ajp.2022.103380. Epub 2022 Dec 5. Asian J Psychiatr. 2023. PMID: 36495830

8

HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.

Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang H, Hu Y, Qiu J, Pu L, Tang J, Wang X. Li Q, et al. Among authors: pu l. Signal Transduct Target Ther. 2021 Feb 23;6(1):76. doi: 10.1038/s41392-020-00453-8. Signal Transduct Target Ther. 2021. PMID: 33619246 Free PMC article.

9

Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030.

Pu L, Wang L, Zhang R, Zhao T, Jiang Y, Han L. Pu L, et al. Stroke. 2023 May;54(5):1330-1339. doi: 10.1161/STROKEAHA.122.040073. Epub 2023 Apr 24. Stroke. 2023. PMID: 37094034 Free article.

10

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial.

Xia Y, Tang W, Qian X, Li X, Cheng F, Wang K, Zhang F, Zhang C, Li D, Song J, Zhang H, Zhao J, Yao A, Wu X, Wu C, Ji G, Liu X, Zhu F, Qin L, Xiao X, Deng Z, Kong X, Li S, Yu Y, Xi W, Deng W, Qi C, Liu H, Pu L, Wang P, Wang X. Xia Y, et al. Among authors: pu l. J Immunother Cancer. 2022 Apr;10(4):e004656. doi: 10.1136/jitc-2022-004656. J Immunother Cancer. 2022. PMID: 35379737 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,223 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,223 results

Results by year